Description
Retatrutide is a novel triple receptor agonist targeting GIP, GLP-1, and glucagon receptors. It represents cutting-edge research in metabolic health and energy balance.
Price range: $185.00 through $225.00
Triple receptor agonist for advanced metabolic research
Retatrutide is a novel triple receptor agonist targeting GIP, GLP-1, and glucagon receptors. It represents cutting-edge research in metabolic health and energy balance.
Reviews
There are no reviews yet.